Respecting patient privacy and autonomy is essential. Patients should have the right to opt out of AI documentation if they’re uncomfortable with it. It’s also important for patients to be informed if genetic information or biomarkers are used to guide decisions. The days of simply telling patients what to do are over—engaging them in their care enhances both understanding and outcomes.

In the past two years, I’ve spent significant time in the Gulf region, particularly in the UAE, Saudi Arabia, Qatar, and Kuwait, where I’ve had the privilege of working with regulators and health systems. I am impressed by the commitment to population health, thoughtful use of technology, and inclusion of youth in the workforce. The Gulf region is at the forefront of these advancements, with both health systems and regulators adopting a technology-informed, population health approach. It’s an exciting time to be involved in healthcare in the GCC.